the problem is how much meat can re-grow on the bone, or it continues to waste over time. The shorts are covering right now, which means the price will go down after the covering is over. This will further shake out some longs in the process.
BIOD should have done it right the first time - They should have done a re-do without the FDA, why maintain a damaged trial, flush it and start over. They needed the FDA to tell them that, what a bunch of dummies. How can one expect the FDA to bend over backwards, they want a clean trial. This is the message to BIOD now - "give us a clean trial" .